Your browser doesn't support javascript.
loading
The UCHL5 inhibitor b-AP15 overcomes cisplatin resistance via suppression of cancer stemness in urothelial carcinoma.
Chow, Po-Ming; Dong, Jun-Ren; Chang, Yu-Wei; Kuo, Kuan-Lin; Lin, Wei-Chou; Liu, Shing-Hwa; Huang, Kuo-How.
Affiliation
  • Chow PM; Department of Urology, National Taiwan University Hospital, Taipei 100, Taiwan.
  • Dong JR; Department of Urology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
  • Chang YW; Department of Urology, National Taiwan University Hospital, Taipei 100, Taiwan.
  • Kuo KL; Department of Urology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
  • Lin WC; Department of Urology, National Taiwan University Hospital, Taipei 100, Taiwan.
  • Liu SH; Department of Urology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
  • Huang KH; Department of Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA.
Mol Ther Oncolytics ; 26: 387-398, 2022 Sep 15.
Article in En | MEDLINE | ID: mdl-36090476
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Oncolytics Year: 2022 Document type: Article Affiliation country: Taiwan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Oncolytics Year: 2022 Document type: Article Affiliation country: Taiwan Country of publication: United States